USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/3552
Title: Noi strategii în tratamentul diabetului zanarat Tip 2
Other Titles: The new strategies in diabetes mellitus treatment
Authors: Bacinschi, Nicolae
Ghicavîi, Victor
Baltag, Natalia
Bacinschi, Andrei
Issue Date: 2009
Publisher: CEP Medicina
Citation: BACINSCHI, Nicolae, GHICAVÎI, Victor, BALTAG, Natalia, BACINSCHI, Aurelia. Noi strategii în tratamentul diabetului zanarat tip 2. In: Anale Ştiințifice ale USMF “Nicolae Testemiţanu”. Ed. a 10-a. Chișinău: CEP Medicina, 2009, vol. 1: Problememedico-biologice si farmaceutice, pp. 277-281
Abstract: The new strategies in diabetes mellitus treatment The rational selection of oral antidiabetics in diabetes mellitus treatment, type II is determined by the influence upon pathogenic way, prevention of insulinoresistance and insulin secretion insufficiency. With this purpose can be utilized sulphonylureic (glybenclamide, glypiyide, glymepiride etc.), biguanides (metphormine), meglytinedes (repaglynide, nateglynide), thyayolidindiones (pioglytazon, roziglytazon), tetrazaharides (acarboze), GLP-1 agonists (exenatid, liraglutid), DPP/IV antagonists and blockers (sitaglipide, vildaglyptide, saxaglyptine), antagonists of GB1 canabinoid reseptors (rimonobant), amilines analogues (pramliptid), ihaled insulin (exiubera). Selectarea raţională a antidiabeticelor orale în tratamentul diabetului zaharat tip 2 este determinată de influenţa asupra verigelor patogenetice, combaterea insulinorezistenţei şi insuficienţei secreţiei insulinei. Cu acest svop se pot utiliza: sulfonilureicele (glibenclamida, glipizida, glimepirida etc.), biguanidele (metformina), meglitinidele (repaglinida, nateglinida), tiazolidindionele (pioglitazon, roziglitazon), tetrazaharidele (acarboza), agoniştii GLP-1 (exenatid, liraglutid), antagoniştii sau blocantele DPP-IV (sitagliptina, vildagliptina, saxagliptina), antagoniştii GB1-receptorilor canabinoizi (rimonobant), analogii amilinei (pramliptid), insulina inhalatoare (exiubera).
URI: http://repository.usmf.md/handle/20.500.12710/3552
Appears in Collections:Farmacologie și farmacologie clinică

Files in This Item:
File Description SizeFormat 
Noi_strategii_in_tratamentul_diabetului_zaharat_TIP_2_1.pdf186.5 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback